Jon M. Foster - Nov 9, 2021 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Role
Group President
Signature
/s/ Natalie Harrison Cline, Attorney-in-Fact
Stock symbol
HCA
Transactions as of
Nov 9, 2021
Transactions value $
-$6,540,618
Form type
4
Date filed
11/12/2021, 04:27 PM
Next filing
Feb 1, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCA Common Stock Gift $0 -4.92K -50% $0.00 4.92K May 12, 2021 Direct
transaction HCA Common Stock Gift $0 +4.92K +11.17% $0.00 49K May 12, 2021 By JMF Trust (Spouse and Robert Nagel, Co-Trustees)
transaction HCA Common Stock Gift $0 -4.92K -100% $0.00* 0 May 12, 2021 Direct
transaction HCA Common Stock Gift $0 +4.92K $0.00 4.92K May 12, 2021 By Spouse
transaction HCA Common Stock Gift $0 -4.92K -100% $0.00* 0 May 13, 2021 By Spouse
transaction HCA Common Stock Gift $0 +4.92K +11.17% $0.00 49K May 13, 2021 By LCF Trust (Reporting Person, Trustee)
transaction HCA Common Stock Options Exercise $1.6M +33.4K $47.97* 33.4K Nov 9, 2021 Direct
transaction HCA Common Stock Tax liability -$4.2M -17.1K -51.18% $246.14 16.3K Nov 9, 2021 Direct
transaction HCA Common Stock Sale -$2.17M -9K -55.24% $241.17 7.29K Nov 11, 2021 Direct F1
transaction HCA Common Stock Sale -$1.7M -7K -95.97% $242.20 294 Nov 11, 2021 Direct F2
transaction HCA Common Stock Sale -$71.4K -294 -100% $242.79 0 Nov 11, 2021 Direct F3
holding HCA Common Stock 20K Nov 9, 2021 By JMF Family Trust (Spouse, Trustee)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HCA Stock Appreciation Right Options Exercise $0 -1.5K -100% $0.00* 0 Nov 9, 2021 Common Stock 1.5K $47.97 Direct F4
transaction HCA Stock Appreciation Right Options Exercise $0 -31.9K -100% $0.00* 0 Nov 9, 2021 Common Stock 31.9K $47.97 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $240.73 to $241.72, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $241.74 to $242.68, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $242.75 to $242.82, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The stock appreciation rights vested in four equal annual installments beginning on February 5, 2015.
F5 The stock appreciation rights vested at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the achievement of certain annual EBITDA performance targets.